{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:12:27Z","timestamp":1789179147325,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd011319","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T00:00:00Z","timestamp":1470268800000}}],"reference-count":68,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011319.pub2","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T15:31:23Z","timestamp":1470324683000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs"],"prefix":"10.1002","volume":"2016","author":[{"given":"Ahmed","family":"Kayssi","sequence":"first","affiliation":[{"name":"University of Toronto; Division of Vascular Surgery; Eaton North, 6th Floor, Room EN 6-214 200 Elizabeth Street Toronto ON Canada M5G 2C4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talal","family":"Al-Atassi","sequence":"additional","affiliation":[{"name":"University of Ottawa Heart Institute; Division of Cardiac Surgery; 40 Ruskin Street Ottawa ON Canada K1Y 4W7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Oreopoulos","sequence":"additional","affiliation":[{"name":"University of Toronto; Division of Vascular Surgery; Eaton North, 6th Floor, Room EN 6-214 200 Elizabeth Street Toronto ON Canada M5G 2C4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Roche-Nagle","sequence":"additional","affiliation":[{"name":"University of Toronto; Division of Vascular Surgery; Eaton North, 6th Floor, Room EN 6-214 200 Elizabeth Street Toronto ON Canada M5G 2C4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kong Teng","family":"Tan","sequence":"additional","affiliation":[{"name":"University of Toronto; Division of Vascular and Interventional Radiology; NCSB 1C-572, 585 University Avenue Toronto ON Canada M5G 2N2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dheeraj K","family":"Rajan","sequence":"additional","affiliation":[{"name":"University of Toronto; Division of Vascular and Interventional Radiology; NCSB 1C-572, 585 University Avenue Toronto ON Canada M5G 2N2"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,8,4]]},"reference":[{"key":"10.1002\/14651858.CD011319.pub2-BIB0001|cit1","unstructured":"A prospective, multi-centre, randomized controlled, first in man study to assess the safety and performance of the Passeo-18 Lux paclitaxel releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in patients with stenosis and occlusion of the femoropopliteal arteries (BIOLUX P-I) clinicaltrials.gov\/ct2\/show\/NCT01221610"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1526602814564383","article-title":"Paclitaxel-releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve-month results from the BIOLUX P-I randomized trial","volume":"22","author":"Scheinert","year":"2015","journal-title":"Journal of Endovascular Therapy"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0003|cit3","unstructured":"Tepe G Schulte K-L Zeller T Lammer J Pfaffinger P Schmidt A Six-month results of the BIOLUX P-I first in man study comparing a paclitaxel-releasing balloon catheter versus an uncoated balloon catheter in femoropopliteal lesions Cardiovascular and Interventional Radiology 2012 S264 5"},{"issue":"Suppl 84","key":"10.1002\/14651858.CD011319.pub2-BIB0004|cit4","first-page":"FV 9.7","article-title":"Twelve-month results of the BIOLUX P-I first-in-man study comparing a paclitaxel-releasing balloon catheter versus an uncoated catheter in femoropopliteal lesions","volume":"42","author":"Zeller","year":"2013","journal-title":"Vasa - Journal of Vascular Diseases"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0005|cit5","unstructured":"BIOTONIK's - first in men study of the Passeo-18 LUX drug releasing PTA balloon catheter vs. the uncoated Passeo 18 balloon catheter in subjects requiring revascularization of infrapopliteal arteries (BIOLUX P-II) clinicaltrials.gov\/ct2\/show\/NCT01867736"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0006|cit6","unstructured":"Deloose K Zeller T Scheinert D Beschorner U BIOLUX P-II: a randomized clinical trial of Passeo-18 Lux DRB vs POBA for the treatment of infrapopliteal artery lesions Journal of the American College of Cardiology 2014"},{"issue":"11 Suppl 1","key":"10.1002\/14651858.CD011319.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"B79","DOI":"10.1016\/j.jacc.2014.07.315","article-title":"BIOLUX P-II: a randomized clinical trial of Passeo-18 lux drug releasing balloon versus plain old balloon angioplasty for the treatment of infrapopliteal artery lesions","volume":"64","author":"Scheinert","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD011319.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/CIRCULATIONAHA.113.001811","article-title":"Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia","volume":"128","author":"Liistro","year":"2013","journal-title":"Circulation"},{"issue":"5","key":"10.1002\/14651858.CD011319.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1583\/JEVT-12-3926MR.1","article-title":"Lower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trial","volume":"19","author":"Fanelli","year":"2012","journal-title":"Journal of Endovascular Therapy"},{"issue":"2","key":"10.1002\/14651858.CD011319.pub2-BIB0010|cit10","first-page":"207","article-title":"The \"DEBELLUM\" - lower limb multilevel treatment with drug eluting balloon - randomized trial: 1-year results","volume":"55","author":"Fanelli","year":"2014","journal-title":"Journal of Cardiovascular Surgery"},{"issue":"13","key":"10.1002\/14651858.CD011319.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1161\/CIRCULATIONAHA.107.735985","article-title":"Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial","volume":"118","author":"Werk","year":"2008","journal-title":"Circulation"},{"issue":"15","key":"10.1002\/14651858.CD011319.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jacc.2014.06.1198","article-title":"Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial","volume":"64","author":"Zeller","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1745-6215-15-63","article-title":"IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial","volume":"15","author":"Zeller","year":"2014","journal-title":"Trials"},{"issue":"21","key":"10.1002\/14651858.CD011319.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2015.09.063","article-title":"Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions 24-month results of IN.PACT SFA","volume":"66","author":"Laird","year":"2015","journal-title":"Journal of the American College of Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD011319.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation"},{"issue":"1","key":"10.1002\/14651858.CD011319.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcin.2013.05.022","article-title":"The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty","volume":"7","author":"Scheinert","year":"2014","journal-title":"JACC. Cardiovascular Interventions"},{"issue":"2","key":"10.1002\/14651858.CD011319.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1406235","article-title":"Trial of a paclitaxel-coated balloon for femoropopliteal artery disease","volume":"373","author":"Rosenfield","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD011319.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/CIRCINTERVENTIONS.112.971630","article-title":"Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial","volume":"5","author":"Werk","year":"2012","journal-title":"Circulation. Cardiovascular Interventions"},{"issue":"1","key":"10.1002\/14651858.CD011319.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jcin.2014.07.023","article-title":"Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial","volume":"8","author":"Tepe","year":"2015","journal-title":"JACC. Cardiovascular Interventions"},{"issue":"7","key":"10.1002\/14651858.CD011319.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa0706356","article-title":"Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg","volume":"358","author":"Tepe","year":"2008","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0021|cit21","unstructured":"Cotavance\u2122 Paclitaxel-coated balloon versus uncoated balloon angioplasty for treatment of in-stent restenosis in SFA and popliteal arteries COPA CABANA Study clinicaltrials.gov\/ct2\/show\/NCT01594684"},{"issue":"1","key":"10.1002\/14651858.CD011319.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1583\/13-4420R.1","article-title":"Paclitaxel-eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries: the DEBATE-ISR study","volume":"21","author":"Liistro","year":"2014","journal-title":"Journal of Endovascular Therapy"},{"issue":"12","key":"10.1002\/14651858.CD011319.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jcin.2013.07.010","article-title":"Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery)","volume":"6","author":"Liistro","year":"2013","journal-title":"JACC. Cardiovascular Interventions"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0024|cit24","unstructured":"Directional atherectomy followed by a paclitaxel-coated balloon to inhibit restenosIs and maintain vessel patency: a pilot study of anti-restenosis treatment clinicaltrials.gov\/ct2\/show\/NCT01366482"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0025|cit25","unstructured":"European study of POBA versus Cotavance paclitaxel coated balloon for the treatment of infrapopliteal lesions in critical limb ischemia clinicaltrials.gov\/ct2\/show\/NCT01260870"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0026|cit26","unstructured":"Femoral artery in-stent restenosis (FAIR) trial clinicaltrials.gov\/ct2\/show\/record\/NCT01305070"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0027|cit27","unstructured":"Tacke J Kieselbach D Schulte KL Presented at the Transcatheter Cardiovascular Therapeutics Conference in Washington, D.C. September 2014"},{"issue":"9","key":"10.1002\/14651858.CD011319.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jcin.2014.04.015","article-title":"Paclitaxel-coated balloon angioplasty versus drug-eluting stenting for the treatment of infrapopliteal long-segment arterial occlusive disease: the IDEAS randomized controlled trial","volume":"7","author":"Siablis","year":"2014","journal-title":"JACC. Cardiovascular Interventions"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0029|cit29","unstructured":"Randomized trial of paclitaxel eluting balloon or conventional balloon for treatment of in-stent restenosis of the superficial femoral artery in patients with symptomatic peripheral artery disease (ISAR-PEBIS) clinicaltrials.gov\/ct2\/show\/NCT01083394"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0030|cit30","unstructured":"Randomized trial of stenting after dilation with or without paclitaxel eluting balloon or atherectomy in patients with symptomatic peripheral artery disease clinicaltrials.gov\/ct2\/show\/NCT00986752"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0031|cit31","unstructured":"A monocenter randomized clinical trial of PAClitaxel drUg-eluting BAlloon versus standard percutaneous transluminal angioplasty to reduce restenosis in patients with in-stent stenoses in the superficial femoral and proximal popliteal artery clinicaltrials.gov\/ct2\/show\/NCT01247402"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0032|cit32","unstructured":"Photoablative atherectomy followed by a paclitaxel-coated balloon to inhibit restenosis in instent femoro-popliteal obstructions clinicaltrials.gov\/ct2\/show\/NCT01298947"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1745-6215-14-87","article-title":"Randomized trial of Legflow\u00ae paclitaxel eluting balloon and stenting versus standard percutaneous transluminal angioplasty and stenting for the treatment of intermediate and long lesions of the superficial femoral artery (RAPID trial): study protocol for a randomized controlled trial","volume":"14","author":"Karimi","year":"2013","journal-title":"Trials"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0034|cit34","unstructured":"Swedish drug-elution trial in peripheral arterial disease - a multicenter, prospective randomized controlled clinical trial based on the Swedish Vascular Registry (SWEDVASC) Platform clinicaltrials.gov\/ct2\/show\/NCT02051088"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0035|cit35","unstructured":"Evaluation of the use of ACOTEC drug-eluting balloon Litos in below-the-knee arteries to treat critical limb ischemia (ACOART-BTK) clinicaltrials.gov\/ct2\/show\/NCT02563535"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0036|cit36","unstructured":"Prospective, multi-center and randomized controlled clinical study to verify effectiveness and safety of drug-eluting balloon in PTA procedure (AcoArt I Study) clinicaltrials.gov\/ct2\/show\/NCT01850056"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0037|cit37","unstructured":"Prospective, multi-center and randomized controlled clinical study to verify effectiveness and safety of drug-eluting balloon in PTA procedure of the infrapopliteal artery clinicaltrials.gov\/ct2\/show\/NCT02137577"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0038|cit38","unstructured":"Advance\u00ae 18PTX\u00ae Balloon Catheter Study: treatment of lesions in superficial femoral artery\/popliteal artery with a paclitaxel-coated balloon clinicaltrials.gov\/ct2\/show\/NCT00776906"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0039|cit39","doi-asserted-by":"crossref","unstructured":"Teichgr\u00e4ber U Phase III multicenter randomized controlled trial to assess the effectiveness of paclitaxel-coated Luminor balloon catheter versus uncoated balloon catheter in the superficial femoral and popliteal arteries to prevent vessel restenosis or reocclusion Presented at the Leipzig Interventional Course; Leipzig, Germany January 2015","DOI":"10.1186\/s13063-016-1657-x"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0040|cit40","unstructured":"Phase III FREERIDE study Freeway randomized angioplasty study clinicaltrials.gov\/ct2\/show\/NCT01960647"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0041|cit41","unstructured":"Pivotal trial of a novel paclitaxel-coated percutaneous angioplasty balloon clinicaltrials.gov\/ct2\/show\/NCT01858428"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0042|cit42","unstructured":"A prospective, multicenter, single blind, randomized, controlled Japanese population trial comparing MD02-LDCB versus standard balloon angioplasty for treatment of femoropopliteal arteries clinicaltrials.gov\/ct2\/show\/NCT01816412"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0043|cit43","unstructured":"A prospective, multicenter, single blind, randomized, controlled trial comparing the Lutonix drug coated balloon versus standard balloon angioplasty for treatment of below-the-knee (BTK) arteries (Lutonix BTK trial) clinicaltrials.gov\/ct2\/show\/NCT01870401"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0044|cit44","unstructured":"Randomized trial of MDT-2113 drug-eluting balloon (DEB) vs. standard PTA for the treatment of atherosclerotic lesions in the superficial femoral artery and\/or proximal popliteal artery clinicaltrials.gov\/ct2\/show\/NCT01947478"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0045|cit45","unstructured":"Paclitaxel coated balloons for prevention of restenosis in small arteries below the knee compared to angioplasty using uncoated balloons clinicaltrials.gov\/ct2\/show\/NCT00696956"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0046|cit46","unstructured":"Prospective, randomized, multicentre clinical study of the Hemoteq Ranger\u2122 paclitaxel-coated PTA balloon catheter (Ranger DCB) in comparison to uncoated PTA balloons in femoropopliteal lesions clinicaltrials.gov\/ct2\/show\/NCT02013193"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0047|cit47","unstructured":"Singapore infra-genicular angioplasty with paclitaxel-eluting balloon for critical limb ischaemia (SINGA-PACLI) trial clinicaltrials.gov\/ct2\/show\/NCT02129634"},{"issue":"6","key":"10.1002\/14651858.CD011319.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1067\/mva.2001.119749","article-title":"Natural history of claudication: long-term serial follow-up study of 1244 claudicants","volume":"34","author":"Aquino","year":"2001","journal-title":"Journal of Vascular Surgery"},{"issue":"2","key":"10.1002\/14651858.CD011319.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1161\/01.CIR.96.2.636","article-title":"Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery","volume":"96","author":"Axel","year":"1997","journal-title":"Circulation"},{"issue":"4","key":"10.1002\/14651858.CD011319.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jvir.2014.12.013","article-title":"Meta-analysis of drug-eluting balloon angioplasty and drug-eluting stent placement for infrainguinal peripheral arterial disease","volume":"26","author":"Baerlocher","year":"2015","journal-title":"Journal of Vascular and Interventional Radiology"},{"issue":"9501","key":"10.1002\/14651858.CD011319.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/S0140-6736(05)67704-5","article-title":"Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial","volume":"366","author":"Adam","year":"2005","journal-title":"Lancet"},{"issue":"5 Suppl","key":"10.1002\/14651858.CD011319.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1016\/j.jvs.2010.02.002","article-title":"Bypass versus angioplasty in severe ischaemia of the leg (BASIL) trial in perspective","volume":"51","author":"Bradbury","year":"2010","journal-title":"Journal of Vascular Surgery"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.jvs.2014.03.235","article-title":"Infrainguinal angioplasty with drug-eluting stents and balloons","volume":"59","author":"Canaud","year":"2014","journal-title":"Journal of Vascular Surgery"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1161\/CIRCINTERVENTIONS.112.969972","article-title":"Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trials","volume":"5","author":"Cassese","year":"2012","journal-title":"Circulation. Cardiovascular Interventions"},{"issue":"24","key":"10.1002\/14651858.CD011319.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/j.jacc.2013.03.034","article-title":"Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies","volume":"61","author":"Dake","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD011319.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/ije\/20.2.384","article-title":"Edinburgh artery study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population","volume":"20","author":"Fowkes","year":"1991","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0057|cit57","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"11","key":"10.1002\/14651858.CD011319.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1161\/CIRCULATIONAHA.106.174526","article-title":"ACC\/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery\/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC\/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation","volume":"113","author":"Hirsch","year":"2006","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jcin.2014.04.015","article-title":"Paclitaxel-coated balloon angioplasty versus drug-eluting stenting for the treatment of infrapopliteal long-segment arterial occlusive disease: the IDEAS randomized controlled trial","volume":"7","author":"Siablis","year":"2014","journal-title":"JACC. Cardiovascular Interventions"},{"issue":"5","key":"10.1002\/14651858.CD011319.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ejvs.2014.02.011","article-title":"Randomized trials for endovascular treatment of infrainguinal arterial disease: systematic review and meta-analysis (part 1: above the knee)","volume":"47","author":"Jens","year":"2014","journal-title":"European Journal of Vascular and Endovascular Surgery"},{"issue":"5","key":"10.1002\/14651858.CD011319.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ejvs.2014.02.012","article-title":"Randomized trials for endovascular treatment of infrainguinal arterial disease: systematic review and meta-analysis (part 2: below the knee)","volume":"47","author":"Jens","year":"2014","journal-title":"European Journal of Vascular and Endovascular Surgery"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jcin.2011.11.010","article-title":"Clinical evaluation of a paclitaxel-eluting balloon for treatment of femoropopliteal arterial disease: 12-month results from a multicenter Italian registry","volume":"5","author":"Micari","year":"2012","journal-title":"JACC. Cardiovascular Interventions"},{"issue":"Suppl S","key":"10.1002\/14651858.CD011319.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-society consensus for the management of peripheral arterial disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"Journal of Vascular Surgery"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0064|cit64","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD011319.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.jacc.2011.05.034","article-title":"First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome","volume":"58","author":"Schmidt","year":"2011","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD011319.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1586\/erd.12.67","article-title":"Drug-coated balloons and their place in treating peripheral arterial disease","volume":"10","author":"Schnorr","year":"2013","journal-title":"Expert Review of Medical Devices"},{"issue":"5","key":"10.1002\/14651858.CD011319.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.jvs.2012.12.069","article-title":"Local drug delivery to prevent restenosis","volume":"57","author":"Seedial","year":"2013","journal-title":"Journal of Vascular Surgery"},{"issue":"6","key":"10.1002\/14651858.CD011319.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1161\/01.CIR.0000137913.26087.F0","article-title":"Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000","volume":"110","author":"Selvin","year":"2004","journal-title":"Circulation"}],"updated-by":[{"DOI":"10.1002\/14651858.cd011319.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD011319.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T08:32:54Z","timestamp":1717662774000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011319.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Vascular Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,8,4]]},"references-count":68,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011319.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,4]]}}}